Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Latest
146.71%
↑ 16% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
126.02%
Historical baseline
PeriodValue
2025146.71%
2024948.62%
2023-32.42%
2022-54.73%
20210.00%
20200.00%
20190.00%
20180.00%